Get App Open
In App
Lending
Lending
Open App
you are here:

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Growth

  • Regular
  • Direct
Category : Sectoral/Thematic
  • NAV
    : ₹ 43.79 0.25%
    (as on 12th September, 2025)
Crisil Rating

Not Rated

Rank not available for the fund
Risk-O-Meter
Very High Risk

The fund has 95.88% investment in domestic equities of which 40.3% is in Large Cap stocks, 16.51% is in Mid Cap stocks, 8.84% in Small Cap stocks.

Suitable For : Investors who have advanced knowledge of macro trends and prefer to take selective bets for higher returns compared to other Equity funds. At the same time, these investors should also be ready for possibility of moderate to high losses in their investments even though overall market is performing better.

This Scheme
VS
  • Benchmark
    BSE Healthcare TRI
  • NA
  • NA
  • Gold
Compare with
  • Date : -
  • NAV : -
  • Date : -
  • Investment : -
  • Value on selected date : -
  • Returns Calculator
  • SIP Calculator
  • VIP (Value Avg)
Amount
  • Investment Date
  • Sell Date
  • Investment Value
    -
  • Sell Value
    -
  • Profit/Loss
    -
  • Annualised Returns
    -
  • Date : -
  • Investment : -
  • Value on selected date : -

Returns (NAV as on 12th September, 2025)

Period Invested for ₹10000 Invested on Latest Value Absolute Returns Annualised Returns Category Avg Rank within Category
1 Week 05-Sep-25 10160.10 1.60% - 1.41% 83/226
1 Month 12-Aug-25 10279.30 2.79% - 3.32% 121/224
3 Month 12-Jun-25 10320.50 3.20% - 2.85% 86/216
6 Month 12-Mar-25 11702.30 17.02% - 16.94% 93/211
YTD 01-Jan-25 10141.30 1.41% - 3.47% 119/201
1 Year 12-Sep-24 10428.70 4.29% 4.29% -0.64% 40/178
2 Year 12-Sep-23 17199.50 72.00% 31.10% 20.08% 5/139
3 Year 12-Sep-22 21721.20 117.21% 29.48% 19.51% 4/114
5 Year 11-Sep-20 28052.50 180.53% 22.88% 23.86% 47/90
Since Inception 13-Jul-18 43790.00 337.90% 22.86% 14.08% 24/199

SIP Returns (NAV as on 12th September, 2025)

Period Invested for ₹1000 SIP Started on Investments Latest Value Absolute Returns Annualised Returns
1 Year 12-Sep-24 12000 12898.71 7.49 % 14.13 %
2 Year 12-Sep-23 24000 30120.5 25.5 % 23.47 %
3 Year 12-Sep-22 36000 55264.9 53.51 % 29.85 %
5 Year 11-Sep-20 60000 109093.51 81.82 % 24.12 %
 

Tax Treatment

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.

Portfolio (Updated on 31st Aug,2025)

Equity Holding : 95.88% | F&O Holdings : 0.00%| Foreign Equity Holdings : 0.00%| Total : 95.88%
No of Stocks : 37 (Category Avg - 44.16) | Large Cap Investments : 40.3%| Mid Cap Investments : 16.51% | Small Cap Investments : 8.84% | Other : 30.22%

Top 10 Stocks in Portfolio

How to read this table?
Stock Invested in Sector Value(Mn) % of Total Holdings 1M Change 1Y Highest Holding 1Y Lowest Holding Quantity 1M Change in Qty
Sun Pharmaceutical Industries Ltd. Pharmaceuticals 7212.8 11.71% 0.02% 15.45% (Sep 2024) 11.69% (Jul 2025) 45.24 L 3.43 L
Dr. Reddys Laboratories Ltd. Pharmaceuticals 5838.1 9.47% 0.62% 9.66% (May 2025) 8.28% (Jan 2025) 46.33 L 3.80 L
Divis Laboratories Ltd. Pharmaceuticals 5689.6 9.23% 1.10% 9.23% (Aug 2025) 1.86% (Nov 2024) 9.28 L 1.75 L
Cipla Ltd. Pharmaceuticals 4556.2 7.39% -0.15% 9.71% (Jan 2025) 6.52% (Sep 2024) 28.67 L -0.95 L
Aurobindo Pharma Ltd. Pharmaceuticals 4021.9 6.53% 0.82% 7.05% (Apr 2025) 4.26% (Sep 2024) 39.13 L 8.56 L
Lupin Ltd. Pharmaceuticals 3353.3 5.44% 0.33% 5.44% (Aug 2025) 3.79% (Jun 2025) 17.70 L 1.52 L
Alkem Laboratories Ltd. Pharmaceuticals 2467 4.00% 0.17% 4.49% (Feb 2025) 1.63% (Oct 2024) 4.65 L 0.00
Mankind Pharma Ltd. Pharmaceuticals 2157.6 3.50% -0.37% 4.2% (Jun 2025) 0.62% (Nov 2024) 8.73 L -0.49 L
Biocon Ltd. Pharmaceuticals 1978.7 3.21% -0.43% 5.02% (Jun 2025) 0% (Sep 2024) 56.80 L 0.00
Gland Pharma Ltd. Pharmaceuticals 1772.8 2.88% -0.33% 4.63% (Sep 2024) 2.88% (Aug 2025) 9.47 L 0.00
- indicates change in weight in the portfolio. # indicates a new entry.
Name Type of Instrument Weight (%)
TREPS TREPS 3.63%
Net Receivables Net Receivables 0.36%
Margin Margin 0.14%

Risk Ratios

Ratios calculated on daily returns for last 3 years (Updated as on 29th August, 2025)

  • Standard Deviation

    Low volatility
    12.61vs14.28
    Category Avg
  • Beta

    High volatility
    0.9vs0.86
    Category Avg
  • Sharpe Ratio

    Better risk adjusted returns
    1.57vs0.84
    Category Avg
  • Treynor's Ratio

    Better risk adjusted returns
    0.22vs0.16
    Category Avg
  • Jensen's Alpha

    Better risk adjusted returns
    4.83vs3.93
    Category Avg

Alternative Funds (Category Peers)

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
Nippon India Taiwan Equity Fund - Direct Plan - Growth NA 389.09 12.63 30.65 52.12 52.14 33.04
Aditya Birla Sun Life International Equity Fund - Direct Plan - Growth NA 249.75 3.43 11.53 19.61 28.71 17.27
Nippon India Japan Equity Fund - Direct Plan - Growth NA 283.56 3.22 10.49 15.86 19.19 18.55
Motilal Oswal Business Cycle Fund - Direct Plan - Growth NA 1976.19 7.24 7.39 17.72 19.09 0.00
Franklin Asian Equity Fund - Direct - Growth NA 259.99 4.52 9.16 16.22 17.55 11.52
Nippon India US Equity Opportunities Fund - Direct Plan - Growth NA 713.51 2.98 5.84 10.54 17.51 18.35
DSP Banking & Financial Services Fund - Direct Plan - Growth NA 1331.23 2.48 -0.26 15.87 15.58 0.00
SBI Banking & Financial Services Fund - Direct Plan - Growth NA 8370.76 1.11 1.39 17.96 12.72 18.73
Baroda BNP Paribas Banking and Financial Services Fund - Direct Plan - Growth NA 295.43 0.96 -0.47 15.12 11.70 16.58
WhiteOak Capital Banking & Financial Services Fund - Direct Plan - Growth NA 468.18 0.75 1.17 17.78 10.93 0.00

More Funds from ICICI Prudential Mutual Fund

Out of 108 mutual fund schemes offered by this AMC, 4 is/are ranked 5 * , 6 is/are ranked 4 * , 13 is/are ranked 3 * , 4 is/are ranked 2 * , 4 is/are ranked 1 * , and 77 schemes are not ranked. See more about AMC

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
ICICI Prudential Large Cap Fund - Direct Plan - Growth 5 71839.85 2.14 2.06 13.91 1.33 18.23
ICICI Prudential Balanced Advantage Fund - Direct Plan - Growth NA 65710.61 2.68 2.83 11.60 6.56 13.68
ICICI Prudential Multi-Asset Fund - Direct Plan - Growth 4 64770.24 3.02 2.43 11.00 8.88 19.96
ICICI Prudential Value Fund - Direct Plan - Growth 4 53750.43 2.02 1.52 12.94 1.30 21.84
ICICI Prudential Liquid Fund - Direct Fund - Growth 1 49438.50 0.47 1.43 3.32 6.96 7.06
ICICI Prudential Equity & Debt Fund - Direct Plan - Growth 4 45151.97 2.96 3.28 13.41 5.11 19.81
ICICI Prudential Money Market Fund - Direct Plan - Growth 3 37886.78 0.44 1.51 4.17 7.95 7.60
ICICI Prudential Corporate Bond Fund - Direct Plan - Growth 2 33452.55 0.37 1.20 4.56 8.49 7.98
ICICI Prudential Equity - Arbitrage Fund - Direct Plan - Growth 3 32592.70 0.43 1.47 3.49 7.17 7.66
ICICI Prudential India Opportunities Fund - Direct Plan - Growth NA 29871.10 2.52 1.43 14.42 1.72 23.71

Forum

+ See More